Cargando…

Value of Neuropsychological Tests to Identify Patients with Depressive Symptoms on the Alzheimer’s Disease Continuum

BACKGROUND: Depressive symptoms often co-occur with Alzheimer’s disease (AD) and can impact neuropsychological test results. In early stages of AD, disentangling cognitive impairments due to depression from those due to neurodegeneration often poses a challenge. OBJECTIVE: We aimed to identify neuro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Menne, Felix, Schipke, Carola Gertrud, Klostermann, Arne, Fuentes-Casañ, Manuel, Freiesleben, Silka Dawn, Bauer, Chris, Peters, Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739969/ https://www.ncbi.nlm.nih.gov/pubmed/33074230 http://dx.doi.org/10.3233/JAD-200710

Ejemplares similares

Plasma Amyloid Concentration in Alzheimer’s Disease: Performance of a High-Throughput Amyloid Assay in Distinguishing Alzheimer’s Disease Cases from Controls
por: Feinkohl, Insa, et al.
Publicado: (2020)

Technology for home dementia care: A prototype locating system put to the test
por: Megges, Herlind, et al.
Publicado: (2017)

Overcoming barriers to the adoption of locating technologies in dementia care: a multi-stakeholder focus group study
por: Freiesleben, Silka Dawn, et al.
Publicado: (2021)

The Cortical Neuroanatomy Related to Specific Neuropsychological Deficits in Alzheimer's Continuum
por: Kang, Sung Hoon, et al.
Publicado: (2019)

A systematic review of agomelatine-induced liver injury
por: Freiesleben, Silka Dawn, et al.
Publicado: (2015)

User experience and clinical effectiveness with two wearable global positioning system devices in home dementia care
por: Megges, Herlind, et al.
Publicado: (2018)

Neurogranin and BACE1 in CSF as Potential Biomarkers Differentiating Depression with Cognitive Deficits from Early Alzheimer's Disease: A Pilot Study
por: Schipke, Carola G., et al.
Publicado: (2018)

Regional cerebral THK5351 accumulations correlate with neuropsychological test scores in Alzheimer continuum
por: Im, SungWoon, et al.
Publicado: (2023)

Distinct expression of the neurotoxic microRNA family let-7 in the cerebrospinal fluid of patients with Alzheimer's disease
por: Derkow, Katja, et al.
Publicado: (2018)

Identification of a Cascade of Changes in Activities of Daily Living Preceding Short-Term Clinical Deterioration in Mild Alzheimer’s Disease Dementia via Lead-Lag Analysis
por: Fuentes, Manuel, et al.
Publicado: (2020)

Depressive Symptom Clusters and Neuropsychological Performance in Mild Alzheimer's and Cognitively Normal Elderly
por: Hall, James R., et al.
Publicado: (2011)

Tele-Neuropsychological Assessment of Alzheimer’s Disease
por: Carotenuto, Anna, et al.
Publicado: (2021)

Technical Review of Clinical Outcomes Assessments Across the Continuum of Alzheimer's Disease
por: DiBenedetti, Dana B., et al.
Publicado: (2023)

Psychometric properties of Cognitive Instruments in Vascular Dementia and Alzheimer’s disease: a neuropsychological study
por: Cecato, Juliana Francisca, et al.
Publicado: (2020)

The Effect of Type 2 Diabetes Mellitus on Neuropsychological Symptoms in Chinese Early Alzheimer’s Disease Population
por: Shi, Qianqian, et al.
Publicado: (2020)

Depressive Symptoms Have Distinct Relationships With Neuroimaging Biomarkers Across the Alzheimer’s Clinical Continuum
por: Moulinet, Inès, et al.
Publicado: (2022)

Cytokines, neurophysiology, neuropsychology, and psychiatric symptoms.
por: Schwarz, Markus J.
Publicado: (2003)

Correlation between overactive bladder symptom score and neuropsychological parameters in Alzheimer’s disease patients with lower urinary tract symptom
por: Jung, Ha Bum, et al.
Publicado: (2017)

Molecular markers of neuropsychological functioning and Alzheimer's disease
por: Edwards, Melissa, et al.
Publicado: (2015)

Anosognosia in Alzheimer's disease: A neuropsychological approach
por: Zilli, Bárbara Bomfim Caiado de Castro, et al.
Publicado: (2007)

Correlation of neurotrophic and neuropsychological parameters in alzheimer’s disease
por: Sidenkova, A.
Publicado: (2021)

Evidence for the Utility of Actuarial Neuropsychological Criteria Across the Continuum of Normal Aging, Mild Cognitive Impairment, and Dementia
por: Graves, Lisa V., et al.
Publicado: (2020)

Lost in space(s): multimodal neuroimaging of disorientation along the Alzheimer’s disease continuum
por: Peters-Founshtein, Gregory, et al.
Publicado: (2023)

Cholinergic white matter pathways along the Alzheimer's disease continuum
por: Nemy, Milan, et al.
Publicado: (2022)

Neuropsychological approaches for the detection and evaluation of toxic symptoms.
por: Fiedler, N
Publicado: (1996)

The Neuropsychological Characteristics in Early Stage of Alzheimer's Patients with Depression
por: Yang, YoungSoon, et al.
Publicado: (2016)

Neuropsychological Rehabilitation in Mild and Moderate Alzheimer’s Disease Patients
por: Ávila, Renata, et al.
Publicado: (2007)

Heterogeneity of Alzheimer’s disease identified by neuropsychological test profiling
por: Nguyen, Truc Tran Thanh, et al.
Publicado: (2023)

On the path to 2025: understanding the Alzheimer’s disease continuum
por: Aisen, Paul S., et al.
Publicado: (2017)

Memory markers in the continuum of the Alzheimer’s clinical syndrome
por: Parra, Mario A., et al.
Publicado: (2022)

The dynamics of plasma biomarkers across the Alzheimer’s continuum
por: Guo, Yu, et al.
Publicado: (2023)

Alzheimer’s disease: a continuum with visual involvements
por: Elvira-Hurtado, Lorena, et al.
Publicado: (2023)

Neuropsychological differences between frontotemporal lobar degeneration and Alzheimer’s disease
por: Porto, Claudia Sellitto, et al.
Publicado: (2008)

Driving and Alzheimer's disease: A neuropsychological screening battery for the elderly
por: Crivelli, Lucía, et al.
Publicado: (2019)

Neuropsychological Comparison of Patients With Alzheimer’s Disease and Dementia With Lewy Bodies
por: Kang, Sungwoo, et al.
Publicado: (2023)

The Inflammatory Continuum of Traumatic Brain Injury and Alzheimer’s Disease
por: Kokiko-Cochran, Olga N., et al.
Publicado: (2018)

Glial activation and inflammation along the Alzheimer’s disease continuum
por: Nordengen, Kaja, et al.
Publicado: (2019)

Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer’s disease continuum
por: Paciotti, Silvia, et al.
Publicado: (2023)

Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
por: Bader, Jakob M, et al.
Publicado: (2020)

Pursuing Experimental Reproducibility: An Efficient Protocol for the Preparation of Cerebrospinal Fluid Samples for NMR-Based Metabolomics and Analysis of Sample Degradation
por: Albrecht, Benjamin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hq9uin43n02dp0d8p89qq1a8qf